Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
OneMedNet ( (ONMD) ) has issued an announcement.
On April 14, 2026, OneMedNet disclosed that it had received a notice from Nasdaq staff stating that the company is no longer in compliance with the exchange’s $1.00 minimum bid price requirement, after its common stock traded below that threshold for 30 consecutive business days. Under Nasdaq rules, OneMedNet now has 180 calendar days, until October 12, 2026, to lift its share price to at least $1.00 for ten straight trading days, and could receive a further 180-day extension if it meets other listing standards and commits to a remedial plan.
The company said it will monitor its share price and may pursue options such as a reverse stock split to regain compliance, but cautioned that there is no guarantee it will succeed, and failure to meet the bid price or other Nasdaq requirements could lead to the stock being delisted from the Nasdaq Capital Market, potentially reducing liquidity and access to capital for shareholders and the business.
More about OneMedNet
OneMedNet Corporation operates in the healthcare and medical data technology sector, focusing on solutions that leverage clinical data and imaging for research, diagnostics, or related healthcare applications. The company’s shares are listed on the Nasdaq Capital Market, giving it access to public equity investors and subjecting it to Nasdaq’s continued listing requirements.
Average Trading Volume: 4,119,581
Technical Sentiment Signal: Sell
Current Market Cap: $46.04M
See more data about ONMD stock on TipRanks’ Stock Analysis page.